Merk's competitor, GlaxoSmithKline has received approval for their rival HPV vaccine, Cervarix. This is a good thing. This is where the "free market" and "capitalism" has a place in medicine - the competition should, hopefully, drive consumer prices down to a more affordable and reasonable rate, for those of us without insurance or beyond the approved age limit for insurance coverage.
http://www.reuters.com/article/pressRelease/idUS158707+16-Oct-2009+PRN20091016
http://www.reuters.com/article/pressRelease/idUS158707+16-Oct-2009+PRN20091016